Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06153797 · ClinicalTrials.gov registry record · NA

A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors

A NA study of Hematologic Malignancy and Caregiver, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06153797 is a NA study of Hematologic Malignancy and Caregiver that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 80 participants, below the 227-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06153797, a NA study of Hematologic Malignancy and Caregiver, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized clinical trial is to evaluate whether a positive psychology intervention (PATH-C) can improve psychological well-being, quality of life, and physical activity in caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT).

Interventions

  • BEHAVIORAL PATH-C

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-01-01
Est. Completion 2027-01-31
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT06153797

The ClinicalTrials.gov registry entry for NCT06153797 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (65% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hematologic Malignancy appearing as the primary indexed condition, and to 1 intervention - of which PATH-C is the first listed.

NCT06153797 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06153797 about?

NCT06153797 is a clinical study titled "A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors". The goal of this randomized clinical trial is to evaluate whether a positive psychology intervention (PATH-C) can improve psychological well-being, quality of life, and physical activity in caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT).

What is the current status of trial NCT06153797?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-01-01. Estimated completion is 2027-01-31.

What conditions does trial NCT06153797 study?

This clinical trial studies the following conditions: Hematologic Malignancy, Caregiver.

What interventions are being tested in trial NCT06153797?

The interventions under investigation include: PATH-C (BEHAVIORAL).

Who is sponsoring clinical trial NCT06153797?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06153797 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematologic Malignancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.